| Escitalopram | Placebo | p |
Number | 15 | 15 |
|
Age | 56.7 ± 6.14 | 57.6 ± 7.30 | 0.71 |
Gender (M:F) | 03:12 | 04:11 |
|
Antihypertensive medicine dose at the study onset | 2.1 ± 0.99 | 2.4 ± 0.74 | 0.31 |
Years of education | 7.2 ± 3.53 | 6.4 ± 3.85 | 0.55 |
Employment (proportion of housewives) | 53% | 46% |
|
Marital status (married) | 66% | 53% |
|
Number of chronic diseases | 1.3 ± 0.51 | 1.4 ± 0.51 | 0,92 |
Smoking | 0 | 0 |
|
Oral contraceptive | 0 | 0 |
|
Sedentary lifestyle | 93% | 66% |
|
Alcohol | 0 | 0 |
|
Initial BMI (kg/m²) | 31.7 ± 5.85 | 29.9 ± 7.29 | 0.47 |
Initial BMI (kg/m²) | 31.8 ± 5.79 | 29.9 ± 7.20 | 0.44 |
SBP time 0 | 144.0 ± 13.50 | 142.2 ± 12.47 | 0.70 |
SBP time 1 | 156.7 ± 14.64 | 152.4 ± 14.23 | 0.42 |
SBP time 2 | 145.6 ± 15.39 | 138.9 ± 16.28 | 0.25 |
SBP time 3 | 145.1 ± 17.62 | 138.5 ± 14.37 | 0.27 |
SBP time 4 | 140.1 ± 15.12 | 140.2 ± 15.83 | 0.97 |
DBP time 0 | 81.8 ± 9.67 | 79.6 ± 9.89 | 0.54 |
DBP time 1 | 88.4 ± 9.28 | 87.4 ± 13.05 | 0.8 |
DBP time 2 | 85.8 ± 11.91 | 80.9 ± 15.02 | 0.32 |
DBP time 3 | 84.2 ± 11.15 | 79.2 ± 13.31 | 0.27 |
DBP time 4 | 80.5 ± 12.06 | 80.4 ± 14.07 | 0.98 |
HR time 0 | 72.3 ± 13.62 | 73.1 ± 13.99 | 0.871 |
HR time 1 | 71.3 ± 8.62 | 74.1 ± 12.20 | 0.473 |
HR time 2 | 69.8 ± 8.12 | 73.9 ± 13.99 | 0.336 |
HR time 3 | 68.5 ± 8.16 | 75.2 ± 11.01 | 0.067 |
HR time 4 | 66.8 ± 9.62 | 74.1 ± 9.55 | 0.0460* |
HAM-D time 1 | 27.9 ± 4.86 | 24.7 ± 5.79 | 0.11 |
HAM-D time 4 | 8.2 ± 7.06 | 8.2 ± 3.48 | 1.00 |
Sleep score time 1 | 4.4 ± 1.84 | 3.2 ± 2.15 | 0.11 |
Sleep score time 4 | 1.8 ± 2.53 | 0.8 ± 0.91 | 0.16 |
Δ time 1 - time 0 SBP | 12.7 ± 17.88 | 10.2 ± 8.34 | 0.63 |
Δ time 0 - 1 time DBP | 6.5 ± 9.27 | 7.7 ± 10.48 | 0.74 |
Δ time 4 - 1 time SBP | −16.6 ± 16.15 | −12.1 ± 13.91 | 0.42 |
Δ time 0 - 1 time DBP | −7.9 ± 9.29 | −6.9 ± 7.70 | 0.77 |
Remitting | 10 (58%) | 7 (42%) | Total 17 |
Non-remitting | 5 (38%) | 8 (61%) | Total 13 |
Normal sleep | 8 (57%) | 6 (43%) | Total 14 |
Sleepless | 7 (43%) | 9 (56%) | Total 16 |